Description of assignment:
Execution of sponsor activities according to GCP on behalf of the Department of Oncology at Rigshospitalet who has the sponsor obligation in a planned investigator initiated phase II trial in cancer with planned start in april 2016. The duties will include regulatory activities, submission to competent authorities, project management, pharmacovigilance services, monitoring at sites in Europe and CSR medical writing
References:
Interested suppliers must submit a list of references regarding experience with the above mentioned service, or corresponding services. We require a minimum of 1 reference with experience in corresponding services within the last 3 years.
The deadline for application is Wednesday, 30 March 2016.